Colorectal Cancer

The American Gastroenterology Association recently spoke out about data that showed colonoscopy screening had a modest benefit in colorectal cancer.

GENEVA — A large percentage of people with colorectal cancer around the world are diagnosed through emergency presentation, according to study results presented at World Cancer Congress.

GENEVA — Exposure to proton pump inhibitors appeared associated with increased risk for certain cancers, according to results of a meta-analysis presented at World Cancer Congress.

GENEVA — Remote interventions led to higher screening rates for breast, cervical and colorectal cancers among women who live in rural areas, according to study results presented at World Cancer Congress.

Despite some sensational headlines following the publication of NordICC trial data in The New England Journal of Medicine, it’s important to understand that this study does not change the value of colonoscopy.

Following publication of NordICC trial data in The New England Journal of Medicine, which found a modest benefit for colonoscopy screening in colorectal cancer, the AGA fired back, noting that colonoscopy is only effective “if it is completed.”

U.S. counties considered more socioeconomically vulnerable had cancer screening rates below federally recommended guidelines, according to study results published in JAMA Network Open.

A deep learning-based instance segmentation model was highly accurate in simultaneously recognizing eight types of surgical instruments in laparoscopic colorectal surgical videos, according to a study published in JAMA Network Open.

The FDA granted 510(k) clearance to Iterative Scopes, in association with Provation, for its computer-aided polyp detection device for adults undergoing colorectal cancer screening, according to a press release.

The addition of bevacizumab to trifluridine and tipiracil extended OS among patients with advanced colorectal cancer, according to a topline data announcement.